212 related articles for article (PubMed ID: 36894035)
1. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.
Guo X; Peng Y; Song Q; Wei J; Wang X; Ru Y; Xu S; Cheng X; Li X; Wu D; Chen L; Wei B; Lv X; Ji G
Gastroenterology; 2023 Aug; 165(2):402-413.e13. PubMed ID: 36894035
[TBL] [Abstract][Full Text] [Related]
2. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
3. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer.
Roy S; Kanda M; Nomura S; Zhu Z; Toiyama Y; Taketomi A; Goldenring J; Baba H; Kodera Y; Goel A
Mol Cancer; 2022 Feb; 21(1):42. PubMed ID: 35139874
[TBL] [Abstract][Full Text] [Related]
5. Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer.
Zhou J; Fan X; Chen N; Zhou F; Dong J; Nie Y; Fan D
J Histochem Cytochem; 2015 Dec; 63(12):922-30. PubMed ID: 26374829
[TBL] [Abstract][Full Text] [Related]
6. A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.
Izumi D; Gao F; Toden S; Sonohara F; Kanda M; Ishimoto T; Kodera Y; Wang X; Baba H; Goel A
EBioMedicine; 2019 Mar; 41():268-275. PubMed ID: 30772302
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
8. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric.
Wu R; Yang C; Ji L; Fan ZN; Tao YW; Zhan Q
BMC Cancer; 2020 Nov; 20(1):1110. PubMed ID: 33198658
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the GClnc1 as a Diagnostic Biomarker in Gastric Cancer Patients and its Link with H. Pylori Infection.
Riahi A; Moqadami A; ALnajar SGI; Alizadeh M; Rajabi A; Safaralizadeh R
Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910430
[TBL] [Abstract][Full Text] [Related]
11. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
12. Plasma Methylated RNF180 for Noninvasive Diagnosis of Gastric Cancer.
Zhao L; Liu Y; Zhang S; Li M
Biomed Res Int; 2022; 2022():6548945. PubMed ID: 36246966
[TBL] [Abstract][Full Text] [Related]
13. S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer.
Zhao Z; Zhang C; Zhao Q
Scand J Gastroenterol; 2020 Mar; 55(3):338-346. PubMed ID: 32172630
[No Abstract] [Full Text] [Related]
14. Feasibility of Plasma-Methylated
Miao J; Liu Y; Zhao G; Liu X; Ma Y; Li H; Li S; Zhu Y; Xiong S; Zheng M; Fei S
Cancer Control; 2020; 27(2):1073274820922559. PubMed ID: 32379490
[TBL] [Abstract][Full Text] [Related]
15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
16. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
17. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction.
Shao Y; Tao X; Lu R; Zhang H; Ge J; Xiao B; Ye G; Guo J
Pathol Oncol Res; 2020 Jul; 26(3):1475-1482. PubMed ID: 31432324
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer.
Zhang K; Shi H; Xi H; Wu X; Cui J; Gao Y; Liang W; Hu C; Liu Y; Li J; Wang N; Wei B; Chen L
Theranostics; 2017; 7(1):213-227. PubMed ID: 28042329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]